Christelle Iliza

Senior Consultant, Regulatory and Market Access Expert

Christelle Iliza is a Canadian expert in drug regulatory affairs and market access, with a specialization in pharmacoeconomics and pharmacoepidemiology. She brings valuable experience from her time at INESSS, where she prepared recommendations for health technology assessments (HTAs) for the Quebec Ministry of Health. Her work in regulatory affairs at a Contract Research Organization (CRO) has further enhanced her organizational and technical expertise in managing complex projects.
Christelle holds a Professional Master’s Degree in Clinical Pharmacology from the Université de Montréal, providing her with a robust foundation in drug development, market access, and clinical research methodologies. Her academic training, combined with extensive practical experience, enables her to expertly assess and present clinical and economic data in regulatory submissions.
Since joining IMAC in 2013, Christelle has held various strategic roles and now serves as a Senior Consultant. She has successfully led numerous submissions to INESSS and CDA, including systematic literature reviews, playing a pivotal role in facilitating the market entry and reimbursement of innovative therapies across Canada.